• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

High or low impact? Triple therapy in chronic obstructive pulmonary disease.

作者信息

McDonald Christine F, Bardin Philip G

机构信息

Respiratory and Sleep Medicine, Austin Hospital, Institute for Breathing and Sleep, University of Melbourne, Melbourne, VIC, Australia.

Monash Lung and Sleep, Monash Health, Hudson Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.

出版信息

Respirology. 2018 Oct;23(10):891-892. doi: 10.1111/resp.13388. Epub 2018 Aug 20.

DOI:10.1111/resp.13388
PMID:30125432
Abstract
摘要

相似文献

1
High or low impact? Triple therapy in chronic obstructive pulmonary disease.高影响还是低影响？慢性阻塞性肺疾病的三联疗法。
Respirology. 2018 Oct;23(10):891-892. doi: 10.1111/resp.13388. Epub 2018 Aug 20.
2
Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.单吸入器三联疗法治疗慢性阻塞性肺疾病患者：系统评价。
Respir Res. 2019 Nov 4;20(1):242. doi: 10.1186/s12931-019-1213-9.
3
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.三联单吸入器超细干粉治疗与长效抗胆碱能药物治疗慢性阻塞性肺疾病（TRINITY）：一项双盲、平行组、随机对照试验。
Lancet. 2017 May 13;389(10082):1919-1929. doi: 10.1016/S0140-6736(17)30188-5. Epub 2017 Apr 3.
4
Fluticasone furoate, umeclidinium bromide, and vilanterol as a combination therapy for chronic obstructive pulmonary disease.氟替卡松乌美溴铵维兰特罗三联治疗慢性阻塞性肺疾病。
Expert Rev Respir Med. 2018 Dec;12(12):997-1005. doi: 10.1080/17476348.2018.1548936. Epub 2018 Nov 28.
5
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials.单吸入器三联疗法与单吸入器双联疗法或单独三联疗法治疗慢性阻塞性肺疾病的效果：系统评价和随机对照试验的荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2019 Jul 11;14:1539-1548. doi: 10.2147/COPD.S200846. eCollection 2019.
6
[Analysis on respiratory rehabilitation in patients with chronic obstructive pulmonary disease aged 40 years or older in China, 2014-2015].[2014 - 2015年中国40岁及以上慢性阻塞性肺疾病患者的呼吸康复分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jul 10;41(7):1014-1020. doi: 10.3760/cma.j.cn112338-20200129-00059.
7
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.特布他林、布地奈德/福莫特罗和茚达特罗/格隆溴铵治疗慢性阻塞性肺疾病（TRIBUTE）的随机对照双盲平行分组研究
Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9.
8
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.一项回顾性研究，旨在评估新开始接受长效单药或联合治疗的慢性阻塞性肺疾病患者的临床特征及开始三联开放治疗的时间。
Int J Chron Obstruct Pulmon Dis. 2017 Jun 21;12:1825-1836. doi: 10.2147/COPD.S129007. eCollection 2017.
9
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease.布地奈德福莫特罗格隆溴铵干粉吸入剂治疗慢性阻塞性肺疾病
Expert Opin Pharmacother. 2018 Aug;19(11):1279-1287. doi: 10.1080/14656566.2018.1498841. Epub 2018 Aug 13.
10
Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?药物输送的新进展：三联疗法是否为慢性阻塞性肺疾病治疗的未来？
Expert Opin Pharmacother. 2011 Aug;12(12):1913-32. doi: 10.1517/14656566.2011.589837. Epub 2011 Jun 30.

引用本文的文献

1
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.意大利慢性阻塞性肺疾病三联吸入疗法德尔菲共识
Multidiscip Respir Med. 2024 Sep 18;19(1):949. doi: 10.5826/mrm.2024.949.
2
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box.慢性阻塞性肺疾病的三联疗法（吸入性糖皮质激素/长效β2受体激动剂/长效抗胆碱能药物）：突破常规思维。
ERJ Open Res. 2019 Feb 11;5(1). doi: 10.1183/23120541.00185-2018. eCollection 2019 Feb.